The relationship between statins and depression: a review of the literature

Bibliography

• Newcomer JW, Hennekens CH. Severe mental illness and risk of cardiovascular disease. JAMA 2007;298:1794-6
   PubMed Web of Science ®Google Scholar
• Seldenrijk A, van Hout HP, van Marwijk HW, et al. Depression, anxiety, and arterial stiffness. Biol Psychiatry 2011;69:795-803
   PubMed Web of Science ®Google Scholar
• Roest AM, Martens EJ, de Jonge P, et al. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol 2010;56:38-46
   PubMed Web of Science ®Google Scholar
• Zorumski C, Rubin E. Psychiatry and clinical neuroscience: a primer. OUP USA; New York: 2011
   Google Scholar
• Moussavi S, Chatterji S, Verdes E, et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851-8
   PubMed Web of Science ®Google Scholar
• Frye CA, Paris JJ, Walf AA, et al. Effects and Mechanisms of 3alpha,5alpha,-THP on emotion, motivation, and reward functions involving pregnane xenobiotic receptor. Front Neurosci 2011;5:136
   PubMedGoogle Scholar
• Geyer MA, Vollenweider FX. Serotonin research: contributions to understanding psychoses. Trends Pharmacol Sci 2008;29:445-53
   PubMed Web of Science ®Google Scholar
• Kearney PM, Blackwell L, Collins R, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008;371:117-25
   PubMed Web of Science ®Google Scholar
• Tonelli M, Lloyd A, Clement F, et al. Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis. CMAJ 2011;183:E1189-202
   Google Scholar
• Pasco JA, Jacka FN, Williams LJ, et al. Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression. Psychother Psychosom 2010;79:323-5
   PubMedGoogle Scholar
• Vevera J, Fisar Z, Kvasnicka T, et al. Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Res 2005;133:197-203
   PubMed Web of Science ®Google Scholar
• Levitan I, Fang Y, Rosenhouse-Dantsker A, et al. Cholesterol and ion channels. Subcell Biochem 2010;51:509-49
   PubMedGoogle Scholar
• Simons K, Ikonen E. How cells handle cholesterol. Science 2000;290:1721-6
   PubMed Web of Science ®Google Scholar
• Lloyd-Evans E, Morgan AJ, He X, et al. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat Med 2008;14:1247-55
   PubMed Web of Science ®Google Scholar
• Pucadyil TJ, Chattopadhyay A. Role of cholesterol in the function and organization of G-protein coupled receptors. Prog Lipid Res 2006;45:295-333
   PubMed Web of Science ®Google Scholar
• Engelberg H. Low serum cholesterol and suicide. Lancet 1992;339:727-9
   PubMed Web of Science ®Google Scholar
• Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990;301:309-14
   PubMed Web of Science ®Google Scholar
• Morgan RE, Palinkas LA, Barrett-Connor EL, et al. Plasma cholesterol and depressive symptoms in older men. Lancet 1993;341:75-9
   PubMed Web of Science ®Google Scholar
• Maes M, Delanghe J, Meltzer HY, et al. Lower degree of esterification of serum cholesterol in depression: relevance for depression and suicide research. Acta Psychiatr Scand 1994;90:252-8
   PubMed Web of Science ®Google Scholar
• Khalid A, Lal N, Trivedi JK, et al. Serum lipids: new biological markers in depression? Indian J Psychiatry 1998;40:217-23
   PubMedGoogle Scholar
• Aijanseppa S, Kivinen P, Helkala EL, et al. Serum cholesterol and depressive symptoms in elderly Finnish men. Int J Geriatr Psychiatry 2002;17:629-34
   PubMed Web of Science ®Google Scholar
• Ancelin ML, Carriere I, Boulenger JP, et al. Gender and genotype modulation of the association between lipid levels and depressive symptomatology in community-dwelling elderly (the ESPRIT study). Biol Psychiatry 2010;68:125-32
   PubMed Web of Science ®Google Scholar
• Fang CY, Egleston BL, Gabriel KP, et al. Depressive symptoms and serum lipid levels in young adult women. J Behav Med 2013;36:143-52
   PubMed Web of Science ®Google Scholar
• Singer SJ, Nicolson GL. The fluid mosaic model of the structure of cell membranes. Science 1972;175:720-31
   PubMed Web of Science ®Google Scholar
• Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science 2010;327:46-50
   PubMed Web of Science ®Google Scholar
• Lewis V, Hooper NM. The role of lipid rafts in prion protein biology. Front Biosci 2011;16:151-68
   Web of Science ®Google Scholar
• Allen JA, Yu JZ, Dave RH, et al. Caveolin-1 and lipid microdomains regulate Gs trafficking and attenuate Gs/adenylyl cyclase signaling. Mol Pharmacol 2009;76:1082-93
   PubMedGoogle Scholar
• Allen JA, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci 2007;8:128-40
   PubMed Web of Science ®Google Scholar
• Rapport MM, Green AA, Page IH. Crystalline serotonin. Science 1948;108:329-30
   PubMed Web of Science ®Google Scholar
• Sjögren B, Hamblin MW, Svenningsson P. Cholesterol depletion reduces serotonin binding and signaling via human 5-HT(7(a)) receptors. Eur J Pharmacol 2006;552:1-10
   PubMedGoogle Scholar
• Sjögren B, Csoregh L, Svenningsson P. Cholesterol reduction attenuates 5-HT1A receptor-mediated signaling in human primary neuronal cultures. Naunyn Schmiedebergs Arch Pharmacol 2008;378:441-6
   PubMedGoogle Scholar
• Choi JH, Zhang SY, Park KW, et al. The association between the T102C polymorphism of the HTR2A serotonin receptor gene and HDL cholesterol level in Koreans. J Biochem Mol Biol 2005;38:238-42
   PubMedGoogle Scholar
• Pucadyil TJ, Chattopadhyay A. Cholesterol modulates the antagonist-binding function of hippocampal serotonin1A receptors. Biochim Biophys Acta 2005;1714:35-42
   PubMedGoogle Scholar
• Bystritsky A, Pontillo D, Powers M, et al. Functional MRI changes during panic anticipation and imagery exposure. Neuroreport 2001;12:3953-7
   PubMed Web of Science ®Google Scholar
• Magnani F, Tate CG, Wynne S, et al. Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin. J Biol Chem 2004;279:38770-8
   PubMedGoogle Scholar
• Linetti A, Fratangeli A, Taverna E, et al. Cholesterol reduction impairs exocytosis of synaptic vesicles. J Cell Sci 2010;123:595-605
   PubMed Web of Science ®Google Scholar
• Wagstaff LR, Mitton MW, Arvik BM, et al. Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy 2003;23:871-80
   PubMed Web of Science ®Google Scholar
• Majewska MD. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol 1992;38:379-95
   PubMed Web of Science ®Google Scholar
• Tanaka M, Sokabe M. Continuous de novo synthesis of neurosteroids is required for normal synaptic transmission and plasticity in the dentate gyrus of the rat hippocampus. Neuropharmacology 2012;62:2373-87
   PubMed Web of Science ®Google Scholar
• Zorumski CF, Paul SM, Izumi Y, et al. Neurosteroids, stress and depression: potential therapeutic opportunities. Neurosci Biobehav Rev 2013;37:109-22
   PubMed Web of Science ®Google Scholar
• Gavrilova VA, Ivanova SA, Gusev SI, et al. Neurosteroids dehydroepiandrosterone and its sulfate in individuals with personality disorders convicted of serious violent crimes. Bull Exp Biol Med 2012;154:89-91
   PubMedGoogle Scholar
• Pinna G, Agis-Balboa RC, Doueiri MS, et al. Brain neurosteroids in gender-related aggression induced by social isolation. Crit Rev Neurobiol 2004;16:75-82
   PubMedGoogle Scholar
• Kassler-Taub K, Woodward T, Markowitz JS. Depressive symptoms and pravastatin. Lancet 1993;341:371-2
   PubMed Web of Science ®Google Scholar
• Duits N, Bos FM. Depressive symptoms and cholesterol-lowering drugs. Lancet 1993;341:114
   PubMed Web of Science ®Google Scholar
• Hyyppa MT, Kronholm E, Virtanen A, et al. Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial. Psychoneuroendocrinology 2003;28:181-94
   PubMed Web of Science ®Google Scholar
• Morales K, Wittink M, Datto C, et al. Simvastatin causes changes in affective processes in elderly volunteers. J Am Geriatr Soc 2006;54:70-6
   PubMed Web of Science ®Google Scholar
• Agostini JV, Tinetti ME, Han L, et al. Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults. J Am Geriatr Soc 2007;55:420-5
   PubMed Web of Science ®Google Scholar
• Shrivastava S, Pucadyil TJ, Paila YD, et al. Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin(1A) receptors. Biochemistry 2010;49:5426-35
   PubMed Web of Science ®Google Scholar
• Mailman T, Hariharan M, Karten B. Inhibition of neuronal cholesterol biosynthesis with lovastatin leads to impaired synaptic vesicle release even in the presence of lipoproteins or geranylgeraniol. J Neurochem 2011;119:1002-15
   PubMedGoogle Scholar
• Endo A, Tsujita Y, Kuroda M, et al. Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Eur J Biochem 1977;77:31-6
   PubMedGoogle Scholar
• Jow GM, Yang TT, Chen CL. Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. J Affect Disord 2006;90:21-7
   PubMed Web of Science ®Google Scholar
• Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012;33:1635-701
   PubMed Web of Science ®Google Scholar
• Brown SL, Salive ME, Harris TB, et al. Low cholesterol concentrations and severe depressive symptoms in elderly people. BMJ 1994;308:1328-32
   PubMedGoogle Scholar
• Stewart RA, Sharples KJ, North FM, et al. Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators. Arch Intern Med 2000;160:3144-52
   PubMedGoogle Scholar
• Bovbjerg VE, McCann BS, Retzlaff BM, et al. Effect of cholesterol-lowering diets on indices of depression and hostility. Ann Behav Med 1999;21:98-101
   PubMedGoogle Scholar
• Feng L, Tan CH, Merchant RA, et al. Association between depressive symptoms and use of HMG-CoA reductase inhibitors (statins), corticosteroids and histamine H(2) receptor antagonists in community-dwelling older persons: cross-sectional analysis of a population-based cohort. Drugs Aging 2008;25:795-805
   PubMed Web of Science ®Google Scholar
• Olson MB, Kelsey SF, Matthews KA, et al. Lipid-lowering medication use and aggression scores in women: a report from the NHLBI-sponsored WISE study. J Womens Health (Larchmt) 2008;17:187-94
   PubMed Web of Science ®Google Scholar
• Pascoe MC, Crewther SG, Carey LM, et al. Inflammation and depression: why poststroke depression may be the norm and not the exception. Int J Stroke 2011;6:128-35
   PubMedGoogle Scholar
• Viscogliosi G, Andreozzi P, Chiriac IM, et al. Depressive symptoms in older people with metabolic syndrome: is there a relationship with inflammation? Int J Geriatr Psychiatry 2013;28:242-7
   PubMedGoogle Scholar
• Quist-Paulsen P. Statins and inflammation: an update. Curr Opin Cardiol 2010;25:399-405
   PubMed Web of Science ®Google Scholar
• Young-Xu Y, Chan KA, Liao JK, et al. Long-term statin use and psychological well-being. J Am Coll Cardiol 2003;42:690-7
   PubMed Web of Science ®Google Scholar
• Stafford L, Berk M. The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression? J Clin Psychiatry 2011;72:1229-35
   PubMed Web of Science ®Google Scholar
• Laudi S, Trump S, Schmitz V, et al. Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin. Am J Physiol Lung Cell Mol Physiol 2007;293:L630-8
   PubMed Web of Science ®Google Scholar
• Uzunova V, Sheline Y, Davis JM, et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 1998;95:3239-44
   PubMed Web of Science ®Google Scholar
• Kim JM, Stewart R, Kim SW, et al. Cholesterol and serotonin transporter polymorphism interactions in late-life depression. Neurobiol Aging 2011;32(2):336-43
   PubMedGoogle Scholar
• Fang CY, Egleston BL, Gabriel KP, et al. Depressive symptoms and serum lipid levels in young adult women. J Behav Med. DOI 10.1007/s10865-012-9409-1
   Google Scholar
• Ruljancic N, Mihanovic M, Cepelak I. Thrombocyte serotonin and serum cholesterol concentration in suicidal and non-suicidal depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2011;35(5):1261-7
   PubMedGoogle Scholar